Frontage Laboratories

Highly Engaged Employees

Frontage Laboratories, founded in 2001, is a Contract Research Organization (CRO) providing integrated, science-driven product development services for pharmaceutical and biotechnology companies. Its expertise spans drug discovery and development, offering comprehensive solutions including drug metabolism and pharmacokinetics (DMPK), analytical testing, formulation development, and manufacturing of preclinical and clinical trial materials. The company also delivers bioanalysis, preclinical safety and toxicology assessment, and early-phase clinical studies, supporting regulatory submissions in the United States, China, and globally.

Operating across 15 locations, Frontage Laboratories employs a substantial team of 1,000-5,000 professionals. This extensive infrastructure supports clients in advancing molecules through development and achieving regulatory compliance. The company's operational scale and scientific depth are key to its role as a development partner. For insights into the personnel driving these critical services, interested parties can view Meet Frontage Laboratories' team.

With reported revenue of $33.2 million and a history of strategic funding, including a $10 million round in 2008, Frontage Laboratories is a key player in the CRO market. The company competes by offering specialized services essential for drug development and regulatory approval. Its financial performance and investment history reflect its established position and growth potential. A deeper dive into its financial metrics is available via Explore financial highlights.